Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-30

FDA Approved: TREPROSTINIL — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approved an original-application generic Treprostinil water solution from Sandoz Inc for the treatment of pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Treprostinil (treprostinil)

Snippet

ORIG AP for TREPROSTINIL (TREPROSTINIL)